the molecular face of red cells. refers to the detection of the molecular basis of an antigen...
TRANSCRIPT
Designer genes
The Molecular face of red cells
What is it?
Refers to the detection of the molecular basis of an antigen rather than the antigen itself
Prerequisites: Knowledge of the molecular
structure Appropriate genotyping methods
A buzzzzz word??
Is there a need?
What are the potential advantages?
Is it sustainable?
Service / research mode?
Some real life scenarios
25 year old - aplastic anemia
O pos few years ago – transfused 25 units of red cells / PRCs etc
Now requires a transfusion
New sample for crossmatch
O Rh Negative
Done on 3 different platforms, using different antisera
History – No transplant
Patient is convinced we have gooooofed – wants an
explanation
Request from OG
27 year old
4th pregnancy at 10 weeks of gestation
1 miscarriage, 2 deaths with severe hydrops
Blood group – O Rh negative, ICT , antibody screen Pos. Anti D – titre 1:256
A question…….
What will the fate of this pregnancy be ?
Indications for DNA typing Fetal DNA analysis
Typing multiply transfused
Serological discrepancies – weak D / ABO Subgroups / AIHA with pos DAT ……
QC of antibody screening /ID RBCs
Routine phenotyping of red cells
RBC Antigens
Products of Genes
Antigens carried by proteins – direct products of genes- Rh / Kell
Antigens carried by Carbohydrates – under the control of genes coding for the glycosyl transferases – ABO / H
Nature of differences
Mostly SNPs
Single amino acid differences
However……….
Multiple alleles can code for a single same antigen!!!!!
Events other than SNPs in the same region – can affect antigen expression
Hence incomplete genotyping may not correlate with phenotyping
The D antigen
Greatest Contribution to health care – in pregnancy
To assess if a D negative Mother is carrying a D positive baby
If mother unsensitised – Anti D given only if baby is Rh positive
If mother sensitised – impact on clinical follow up
Fetal DNA in maternal serum
Previously fetal DNA testing done on Amniocentesis samples
Now - found that sufficient amount of fetal DNA is present in sera of mothers
About 3-10% of free plasma DNA in pregnant mothers is fetal. Clears rapidly post pregnancy
Cell free fetal DNA
Occurs due to apoptosis and necrosis etc of placental tissue
Part of a process of physiological remodelling
Results in ffDNA getting released into maternal plasma
From when?
1st trimester
Average 17 weeks
When can it be done?
Akolekar et al – 11 – 13 weeks of pregnancy
High throughput robotic technique 100% pos predictive value 96.5% negative predictive value
Cardo et al - sensitivity of 100% and a specificity of 93%, with a 97% diagnostic accuracy for RhD genotyping
first trimester of pregnancy using a quantitative PCR
Sensitivity -----
Compared to post natal serology
Muller et al – 2008
>1000 typings
25 weeks of pregnancy
>99.6% concordance
Platforms available
Real time PCR
The luminex platform
Automated High throughput analysers using these technologies available
Blood chip technology
The Multiply transfused
Cannot be typed by serology – mixed field reaction seen
DNA from WBC – Accurate type
Epithelia also can be used
Helps select blood for transfusion
Multiply transfused - contd
Likely to be sensitised
Worth antigen matching
If sensitised – can attempt to antigen match henceforth – to prevent further sensitisation